ArticleThe Lancet regional health. Western Pacific2024

Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 study.

Yue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.